SummaryThe reduction in the efficacy of therapeutic antibiotics represents a global problem of increasing intensity and concern. Nitrofuran antibiotics act primarily through the formation of covalent adducts at the N2 atom of the deoxyguanosine nucleotide in genomic DNA. These adducts inhibit replicative DNA polymerases (dPols), leading to the death of the prokaryote. N2-furfuryl-deoxyguanosine (fdG) represents a stable structural analog of the nitrofuran-induced adducts. Unlike other known dPols, DNA polymerase IV (PolIV) from E. coli can bypass the fdG adduct accurately with high catalytic efficiency. This property of PolIV is central to its role in reducing the sensitivity of E. coli toward nitrofuran antibiotics such as nitrofurazone (N...
Imidazopyrazinones (IPYs) are a new class of compounds that target bacterial topoisomerases as a bas...
<i>N</i><sup>2</sup>-Furfuryl-deoxyguanosine (fdG) is carcinogenic DNA adduct that originates from f...
SummaryTuberculosis continues to be a global health threat, making bicyclic nitroimidazoles an impor...
SummaryThe reduction in the efficacy of therapeutic antibiotics represents a global problem of incre...
The reduction in the efficacy of therapeutic antibiotics represents a global problem of increasing i...
Nitrofurazone is reduced by cellular nitroreductases to form N2-deoxyguanine (N2-dG) adducts that ar...
Nitrofurazone is reduced by cellular nitroreductases to form N2-deoxyguanine (N2-dG) adducts that ar...
The mechanism of action of nitrofurantoin against the Escherichia coli K12 strain AB1157 was investi...
DinB, the E. coli translesion synthesis polymerase, has been shown to bypass several N[superscript 2...
DinB (DNA Pol IV) is a translesion (TLS) DNA polymerase, which inserts a nucleotide opposite an othe...
Nitrofurans are “old” antibacterials that are regaining popularity over the past decade due to the l...
DinB, the E. coli translesion synthesis polymerase, has been shown to bypass several N2-alkylguanine...
DinB, the E. coli translesion synthesis polymerase, has been shown to bypass several N2-alkylguanine...
The number of infections caused by microorganisms that are resistant to antibiotics and synthetic an...
Mini-mu derivatives carrying plasmid replicons can be used to clone genesin vivo. This method was ad...
Imidazopyrazinones (IPYs) are a new class of compounds that target bacterial topoisomerases as a bas...
<i>N</i><sup>2</sup>-Furfuryl-deoxyguanosine (fdG) is carcinogenic DNA adduct that originates from f...
SummaryTuberculosis continues to be a global health threat, making bicyclic nitroimidazoles an impor...
SummaryThe reduction in the efficacy of therapeutic antibiotics represents a global problem of incre...
The reduction in the efficacy of therapeutic antibiotics represents a global problem of increasing i...
Nitrofurazone is reduced by cellular nitroreductases to form N2-deoxyguanine (N2-dG) adducts that ar...
Nitrofurazone is reduced by cellular nitroreductases to form N2-deoxyguanine (N2-dG) adducts that ar...
The mechanism of action of nitrofurantoin against the Escherichia coli K12 strain AB1157 was investi...
DinB, the E. coli translesion synthesis polymerase, has been shown to bypass several N[superscript 2...
DinB (DNA Pol IV) is a translesion (TLS) DNA polymerase, which inserts a nucleotide opposite an othe...
Nitrofurans are “old” antibacterials that are regaining popularity over the past decade due to the l...
DinB, the E. coli translesion synthesis polymerase, has been shown to bypass several N2-alkylguanine...
DinB, the E. coli translesion synthesis polymerase, has been shown to bypass several N2-alkylguanine...
The number of infections caused by microorganisms that are resistant to antibiotics and synthetic an...
Mini-mu derivatives carrying plasmid replicons can be used to clone genesin vivo. This method was ad...
Imidazopyrazinones (IPYs) are a new class of compounds that target bacterial topoisomerases as a bas...
<i>N</i><sup>2</sup>-Furfuryl-deoxyguanosine (fdG) is carcinogenic DNA adduct that originates from f...
SummaryTuberculosis continues to be a global health threat, making bicyclic nitroimidazoles an impor...